Page last updated: 2024-08-23

bromocriptine and 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide

bromocriptine has been researched along with 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
D'Angelo, V; Di Fazio, P; Dicembrino, F; Liuzzi, A; Scarabino, T; Scillitani, A; Vettori, PP	1
Emrich, D; Hajak, G; Kögler, A; Munz, DL; Riemann, H; Rüther, E; Staedt, J; Stoppe, G	1
Hartman, NG; Lavigne, GJ; Lobbezoo, F; Montplaisir, JY; Soucy, JP	1
Ambrosio, G; Battista, C; Cascini, GL; Mansi, L; Panza, N; Rambaldi, PF; Schillirò, F	1

Trials

2 trial(s) available for bromocriptine and 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide

Article	Year
Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS). Journal of neural transmission. General section, 1995, Volume: 99, Issue:1-3 Topics: Aged; Benzamides; Brain; Brain Chemistry; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Middle Aged; Myoclonus; Polysomnography; Pyrrolidines; Receptors, Dopamine D2; Sleep Wake Disorders; Tomography, Emission-Computed, Single-Photon	1995
Effects of the D2 receptor agonist bromocriptine on sleep bruxism: report of two single-patient clinical trials. Journal of dental research, 1997, Volume: 76, Issue:9 Topics: Adult; Benzamides; Bromocriptine; Bruxism; Corpus Striatum; Cross-Over Studies; Dizziness; Dopamine Agonists; Dopamine Antagonists; Double-Blind Method; Electromyography; Female; Humans; Iodine Radioisotopes; Male; Masseter Muscle; Nausea; Patient Dropouts; Placebos; Polysomnography; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine; Sleep; Tomography, Emission-Computed, Single-Photon; Treatment Outcome	1997

Article

Year

Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS).

Journal of neural transmission. General section, 1995, Volume: 99, Issue:1-3

Topics: Aged; Benzamides; Brain; Brain Chemistry; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Middle Aged; Myoclonus; Polysomnography; Pyrrolidines; Receptors, Dopamine D2; Sleep Wake Disorders; Tomography, Emission-Computed, Single-Photon

1995

Effects of the D2 receptor agonist bromocriptine on sleep bruxism: report of two single-patient clinical trials.

Journal of dental research, 1997, Volume: 76, Issue:9

Topics: Adult; Benzamides; Bromocriptine; Bruxism; Corpus Striatum; Cross-Over Studies; Dizziness; Dopamine Agonists; Dopamine Antagonists; Double-Blind Method; Electromyography; Female; Humans; Iodine Radioisotopes; Male; Masseter Muscle; Nausea; Patient Dropouts; Placebos; Polysomnography; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine; Sleep; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

1997

Other Studies

2 other study(ies) available for bromocriptine and 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide

Article	Year
In vivo visualization of pituitary dopaminergic receptors by iodine-123 methoxybenzamide (IBZM) correlates with sensitivity to dopamine agonists in two patients with macroprolactinomas. The Journal of clinical endocrinology and metabolism, 1995, Volume: 80, Issue:8 Topics: Adult; Benzamides; Brain; Bromocriptine; Female; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Pyrrolidines; Receptors, Dopamine; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon	1995
Receptor imaging with 111In-pentreotide and 123I-methoxybenzamide, and inhibition tests with octreotide and bromocriptine of mixed growth hormone/prolactin-secreting pituitary tumors. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1999, Volume: 53, Issue:7 Topics: Adult; Benzamides; Bromocriptine; Contrast Media; Growth Hormone; Humans; Indium Radioisotopes; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Prolactin; Pyrrolidines; Radionuclide Imaging; Tomography	1999

Article

Year

In vivo visualization of pituitary dopaminergic receptors by iodine-123 methoxybenzamide (IBZM) correlates with sensitivity to dopamine agonists in two patients with macroprolactinomas.

The Journal of clinical endocrinology and metabolism, 1995, Volume: 80, Issue:8

Topics: Adult; Benzamides; Brain; Bromocriptine; Female; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Pyrrolidines; Receptors, Dopamine; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon

1995

Receptor imaging with 111In-pentreotide and 123I-methoxybenzamide, and inhibition tests with octreotide and bromocriptine of mixed growth hormone/prolactin-secreting pituitary tumors.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1999, Volume: 53, Issue:7

Topics: Adult; Benzamides; Bromocriptine; Contrast Media; Growth Hormone; Humans; Indium Radioisotopes; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Prolactin; Pyrrolidines; Radionuclide Imaging; Tomography

1999